New CDC guidelines suggest that surfaces are a "low-risk" for COVID transmission - cleaning surfaces with detergent or soap once a day should be enough to reduce possible virus levels.
The UK's medical authorities cleared continued use of AstraZeneca, but say that 18-29 year olds should take an alternative vaccine to AstraZeneca if possible.
Professor Paramala Santosh, CEO of HealthTracker Ltd, co-developed the HealthTrackerTM platform – developed by clinicians, assisted by patients for patients, clinicians & researchers, more of which we learn about here.
In an investigation of over seven million pupils, researchers found that Black pupils have the highest rate of autism in the UK - they further noticed that there is "little research" on the existence of autism in ethnic minorities.
The NHS released new information explaining that there would be a vaccine shortage in the UK from 29 March, meaning under-50s will wait longer for their first jab as second doses are given to the most vulnerable cohorts.
Scientists at the University of Pittsburgh are creating COVID-19 antibodies in llamas, to understand how humans could engineer better immune responses.
José Bastos, Director at knok, explores how data from remote diagnosis will alter healthcare and discusses how knok will play its part in this digital transformation journey.
According to radiologists at Massachusetts General Hospital (MGH), swollen lymph nodes after COVID vaccination are a "normal reaction that typically goes away with time".
The Government unveiled the confirmed priority groups for phase two of UK vaccinations - the Joint Committee on Vaccination and Immunisation (JCVI) is choosing age as the deciding factor.
Israel is currently leading the world in COVID vaccination, with real-world data to suggest that the Pfizer vaccine is working to stop 92% of severe COVID cases.
Early stage data from the vaccine rollout in the UK appears to show that COVID hospitalisation and death are reduced by over 75% in people with the Pfizer vaccine.
COVID brought the idea of mRNA vaccines to the attention of the world - now, cancer researchers are investigating how a similar vaccine could stop tumours in a single treatment.
